Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PROSER1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | RRAD | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | ZNF322 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | ATP8B1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | SAMD3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | EIF3E | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | UCP2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | DDX19B | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | RFX1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |